XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings per Share
9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
The Company has unvested restricted stock units outstanding that are considered participating securities and, therefore, computes basic and diluted earnings per share under the two-class method. Basic earnings per share for the periods are based upon the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share include the effect of certain stock options.
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2017
 
2016
 
2017
 
2016
Net income attributable to Westlake Chemical
   Corporation
 
$
210,832

 
$
65,662

 
$
501,849

 
$
299,914

Less:
 
 
 
 
 
 
 
 
Net income attributable to participating securities
 
(1,117
)
 
(294
)
 
(2,630
)
 
(1,347
)
Net income attributable to common shareholders
 
$
209,715

 
$
65,368

 
$
499,219

 
$
298,567


The following table reconciles the denominator for the basic and diluted earnings per share computations shown in the consolidated statements of operations:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2017
 
2016
 
2017
 
2016
Weighted average common shares—basic
 
129,069,186

 
128,793,661

 
129,033,597

 
129,519,577

Plus incremental shares from:
 
 
 
 
 
 
 
 
Assumed exercise of options
 
819,782

 
586,295

 
756,368

 
584,320

Weighted average common shares—diluted
 
129,888,968

 
129,379,956

 
129,789,965

 
130,103,897

 
 
 
 
 
 
 
 
 
Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
 
 
Basic
 
$
1.62

 
$
0.51

 
$
3.87

 
$
2.31

Diluted
 
$
1.61

 
$
0.51

 
$
3.85

 
$
2.29


Excluded from the computation of diluted earnings per share are options to purchase 335,276 and 620,010 shares of common stock for the three months ended September 30, 2017 and 2016, respectively, and 291,888 and 577,254 shares of common stock for the nine months ended September 30, 2017 and 2016, respectively. These options were outstanding during the periods reported but were excluded because the effect of including them would have been antidilutive.